Modeling tumor immunology

Mathematical Models and Methods in Applied Sciences

Volumn 16, Issue SUPPL. 1, 2006, Pages 1091-1124

  Lollini, P L ^a   Motta, S ^b   Pappalardo, F ^b  

^a Dipartimento di Patologia Sperimentale   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cancer vaccines; Modeling; Tumor immunoprevention

Indexed keywords

EID: 33750036131     PISSN: 02182025     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218202506001479     Document Type: Article

References (26)

1. A. K. Abbas and A. H. Lichtman, Cellular and Molecular Immunology, 5th edn. (Elsevier, 2005).
2. N. Bellomo, E. De Angelis and L. Preziosi, Multiscale modeling and mathematical problems related to tumor evolution and medical therapy, J. Theor. Med. 5 (2003) 111-136.
3. N. Bellomo, A. Belloquid and M. Delitala, Mathematical topics on the modelling of multicellular systems in the competition between tumor and immune cells, Math. Mod. Meth. Appl. Sci. 14 (2004) 1683-1733.
4. N. Bellomo and P. Maini, Preface and Special issue on multiscale cancer modelling - A new frontier in applied mathematics, Math. Mod. Meth. Appl. Sci. 15 (2005) iii-viii.
5. A. Belloquid and M. Delitala, Mathematical methods and tools of kinetic theory towards modelling complex biological systems, Math. Mod. Meth. Appl. Sci. 15 (2005) 1639-1666.
6. K. Boggio, G. Nicoletti, E. Di Carlo, F. Cavallo, L. Landuzzi, C. Melani, M. Giovarelli, I. Rossi, P. Nanni, C. De Giovanni, P. Bouchard, S. Wolf, A. Modesti, P. Musiani, P.-L. Lollini, M. P. Colombo and G. Forni, Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice, J. Exp. Med. 188 (1998) 589-596.
7. F. Cavallo, P. Signorelli, M. Giovarelli, P. Musiani, A. Modesti, M. J. Brunda, M. P. Colombo and G. Forni, Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12, J. Natl. Cancer Inst. 89 (1997) 1049-1058.
8. C. De Giovanni, G. Nicoletti, L. Landuzzi, A. Astolfi, S. Croci, A. Comes, S. Ferrini, R. Meazza, M. Iezzi, E. Di Carlo, P. Musiani, F. Cavallo, P. Nanni and P.-L. Lollini, Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine, Cancer Res. 64 (2004) 4001-4009.
9. G. P. Dunn, L. J. Old and R. D. Schreiber, The immunobiology of cancer immunosurveillance and immunoediting, Immunity 21 (2004) 137-148.
10. J. D. Farmer, N. Packard and A. S. Perelson, The immune system, adaption and machine learning, Physica D 22 (1986) 187-204.
11. P.-L. Lollini, C. De Giovanni, L. Landuzzi, G. Nicoletti, F. Frabetti, F. Cavallo, M. Giovarelli, G. Forni, A. Modica, A. Modesti, P. Musiani and P. Nanni, Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: Efficient MHC expression and inhibition of tumor and metastasis growth, Hum. Gene Ther. 6 (1995) 743-752.
12. P.-L. Lollini, G. Nicoletti, L. Landuzzi, C. De Giovanni and P. Nanni, New target antigens for cancer immunoprevention, Curr. Cancer Drug Targets 5 (2005) 221-228.
13. P.-L. Lollini, S. Motta and F. Pappalardo, Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator, preprint.
14. P. Matzinger, An innate sense of danger, Immunology 10 (1998) 399-415.
15. M. Mitchell, An Introduction to Genetic Algorithm (The MIT Press, 1996).
16. D. Morpurgo, R. Serenthà, P. E. Seiden and F. Celada, Modelling thymic functions in a cellular automaton, Int. Immunol. 7 (1995) 505-516.
17. S. Motta and V. Brusic, Modelling in Molecular Biology (Springer, 2004).
18. S. Motta, P.-L. Lollini, F. Castiglione and F. Pappalardo, Modelling vaccination schedules for a cancer immunoprevention vaccine, Immunome Res. 1 (2005) doi:10.1186/1745-7580-1-5.
19. P. Nanni, G. Nicoletti, C. De Giovanni, L. Landuzzi, E. Di Carlo, F. Cavallo, S. M. Pupa, I. Rossi, M. P. Colombo, C. Ricci, A. Astolfi, P. Musiani, G. Forni and P.-L. Lollini, Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice, J. Exp. Med. 194 (2001) 1195-1205.
20. L. Novellino, C. Castelli and G. Parmiani, A listing of human tumor antigens recognized by T cells: March 2004 update, Cancer Immunol. Immunother. 54 (2005) 187-207.
21. F. Pappalardo, P.-L. Lollini, F. Castiglione and S. Motta, Modelling and simulation of cancer immunoprevention vaccine, Bioinfor. 21 (2005) 2891-2897.
22. F. Pappalardo, E. Mastriani, P.-L. Lollini and S. Motta, Genetic Algorithm against Cancer, Lectures Notes in Computer Science, Vol. 3849 (Springer-Verlag, 2006), pp. 223-228.
23. I. Rossi, G. Nicoletti, L. Landuzzi, F. Frabetti, C. De Giovanni, P. Nanni, P. Musiani, M. Ferrantini, F. Belardelli and P.-L. Lollini, Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells, Clin. Exp. Metastasis. 16 (1998) 123-128.
24. L. A. Segel and A. S. Perelson, Some reflections on memory in shape spaces, in Coll. of Theories of Immune Networks, eds. H. Atlan and I. R. Cohen (Springer, 1989).
25. γ and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature 410 (2001) 1107-1111.
26. J. Poterba and L. Summers, Mean reversion in stock prices: Evidence and implications, J. Fin. Econ. 22 (1988) 27-59.